Zantac Cancer Lawsuits: An In-Depth Look
The Recall of Zantac by Sanofi
In October 2019, Sanofi, a French pharmaceutical company, recalled the popular heartburn medication Zantac in the US and Canada. This decision followed an FDA alert that certain versions of the drug contained low levels of N-nitrosodimethylamine (NDMA), a substance known to cause cancer.
NDMA, identified in Zantac, is a type of nitrosamine with carcinogenic properties. The discovery of NDMA in the drug raised significant health concerns, prompting urgent action from both the manufacturer and regulatory bodies.
Pre-Recall Actions by Major Pharmacies
Prior to Sanofi’s recall, major pharmacies like Walgreens, CVS, and Walmart had already removed Zantac from their shelves, reflecting the seriousness of the FDA’s findings. FDA’s Safety Alert on Zantac.
Legal Recourse for Affected Individuals
For those who developed cancer after using Zantac, there are legal options to consider. The Levensten Law Firm offers assistance in understanding and pursuing these options.
Contact The Levensten Law Firm, P.C. for Zantac-Related Claims Our firm is dedicated to helping individuals impacted by Zantac explore their rights to compensation through filing a claim.